Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-18

Clinical Trial Update: Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluated the role of antioxidants in unexplained oligohydramnios; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Oilgohydramnios | Phase 4 | Status: COMPLETED